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Human rabies in South Africa is largely due to infection with the classical rabies virus (genotype 1), with the yellow mongoose 
the commonest vector except in KwaZulu-Natal, Eastern Cape, Mpumalanga and now Limpopo provinces where the dog is 
predominantly responsible for most bites. Rabies is always fatal in humans but can be prevented by timeous administration of 
post exposure prophylaxis( PEP).  This article discusses an evidence-based approach to rabies management in South Africa.
Introduction:
Animal rabies is endemic in South Afri-
ca and causes 10 to 30 laboratory-con-
firmed human deaths annually. It is likely 
that the number of actual human cases 
is significantly higher with patients either 
dying in the community or the disease 
unrecognized by health professionals 
as a possible cause of any encephali-
tis-type illness. Human rabies in South 
Africa is largely due to infection with the 
classical rabies virus (genotype 1) with 
the Duvenhage virus (genotype 4) to 
date identified in only two human infec-
tions, both of which followed bat expo-
sures.1,2 Both wild and domestic animals 
are important reservoirs, with dogs be-
ing the major vector for human disease. 
Major vectors responsible for transmis-
sion vary geographically in South Afri-
ca (Figure 1). 
Rabies virus gains entry into the hu-
man host by the introduction of virus-
containing saliva into a bite wound, 
or by saliva contamination of mucous 
membranes of the mouth, eyes, na-
sal passages and broken skin. After a 
variable period of local virus prolifera-
tion in non-neural tissue, it gains entry 
into the peripheral nerves and is trans-
ported along afferent axons to the cen-
tral nervous system (CNS) leading to an 
almost uniformly fatal encephalitis. Ra-
bies has the highest fatality of any hu-
man infection, but appropriate and time-
ous post exposure preventative treat-
ment is highly effective in preventing ra-
bies disease.2    
Figure 1:  Rabies is endemic to South Africa.  The major vectors of the disease involved are in-
dicated on the diagram.  
(Reprinted with permission from Rabies: Guide to Medical, Veterinary and Allied Professions. Department of Agriculture, South Africa)
CASE 1 
A 4-year-old child on a farm in KwaZulu-Natal was bitten on the face by the family dog and 
sustained a 1cm laceration on the cheek. The attack was unprovoked; the dog was unusual-
ly aggressive, died 2 days later and was buried immediately. The vaccination history of the 
dog was unclear. How would you manage this child? 
CASE 2 
A 10-year-old child presented with pain in the arm, fever and headache followed by an ill-
ness characterized by periods of lucidity, hallucinations and confusion. There was a history 
of a dog bite two months ago on the arm. The patient received tetanus vaccination and anti-
biotic at a local clinic after the bite incident.  What are the differential diagnoses and indi-
cate the laboratory investigations you would do?
The following three scenarios related to actual or potential animal bite exposures are 
presented for your consideration.
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CASE 3
A newly-qualified game guide is going to work in Zambia, doing surveillance work on zoonot-
ic diseases.  He asks your advice about personal prevention of rabies. What would be your 
response to his request?
CASE 1 
This incident occurred in a rabies-en-
demic area and was unprovoked. Pre-
vention of rabies disease in this child is 
mandatory. In addition, the bite is on the 
face and this could be associated with 
a shorter incubation period and even 
greater risk of disease.  Although there 
is no confirmation of rabies in the ani-
mal, the absence of vaccination records 
for the dog and its behaviour should 
raise concerns about the risk of rabies. 
Since rabies is always fatal in humans, 
post-exposure prophylaxis (PEP) or post-
exposure treatment (PET) may be life-
saving and should be instituted immedi-
ately. The principles of PEP or PET  are: 
remove free virus from tissues by wash-
ing; neutralize virus by passive immuni-
ty and induce a rabies virus-specific im-
mune response in the exposed individu-
al before rabies virus can replicate in the 
central nervous system (CNS).
PET should always be given if there 
is the slightest suspicion that the ani-
mal may be rabid. It is crucial to consid-
er the following: 
1.  Species of animal involved: impor-
tant animal species associated with 
rabies in Africa are dogs, cats, cat-
tle, mongooses, foxes, and jackals 
(no transmission from mice, rats or 
vervet monkeys and two cases re-
lated to baboons in South Africa. Ra-
bies-associated viruses are associat-
ed with bats in South Africa.
2.  Behaviour of the animal:  provoked 
or unprovoked attacks; rabid animals 
are usually aggressive but rabid wild 
animals may on occasion appear 
“tame”.  Frequently cattle and goats 
appear to choke due to an apparent 
‘bone in the throat’.
3.  Category of exposure: PET must be 
administered in category 2 and 3 ex-
posures (Table I). 
 •  Under no circumstance should 
PET be delayed pending confir-
matory laboratory tests in the an-
imal.
 •  There is no blood test in the pa-
tient to confirm or exclude rabies 
transmission from the animal and 
the decision to give PET is based 
entirely on the perceived risk of ra-
bies. 
 •  PET should not be withheld even if 
there has been a delay in the per-
son presenting to the health facili-
ty, although efficacy may be sub-
optimal. 
 •  Vaccination history of the animal 
may be unreliable and animals 
that have been vaccinated before 
3 months of age and those who 
have not received boosters may 
not be protected from rabies.
Management of the patient exposed 
to a potentially rabid animal 3,4,5
a.  General wound management is 
critical in all patients: *
 •  The bite site should be well flushed 
with soap and water or water alone 
for at least 5 minutes before apply-
ing disinfectant e.g. 70% alcohol 
or iodine solution
 •  It is advisable to avoid suturing of 
the bite wound and the use of local 
anaesthetics
b.  Further specific management de-
pends on category of rabies expo-
sure (Table I)
 •  Vaccine course in category 2 and 
3 exposures
 •  Addition of rabies immunoglobulin 
in category 3 exposures is critical
c.  Role of human rabies vaccine φ
  Human rabies vaccines available in 
South Africa are cell-derived, either 
produced on VERO cells (Verorab®) 
or chick embryo cells (Rabipor®). 
Cell derived-vaccines are of high effi-
cacy and safe with few adverse reac-
tions. The vaccines must be adminis-
tered intramuscularly into the deltoid, 
or anterolateral thigh in children, but 
NEVER into the buttocks as the im-
mune response may be suboptimal. 
The dosage varies according to man-
ufacturers, but it is usually 0.5 – 1ml. 
The full course must be administered 
to affect an adequate and prolonged 
immune response. 
 A vaccine course comprises of 5 
vaccines administered on days 0, 3, 
7, 14, and 28, with day 0 being the 
day of the first vaccine administra-
tion. The vaccine is ideally given as 
soon as possible after exposure, and 
should still be given even if a patient 
presents some time after the expo-
sure. The paediatric and adult dose 
is the same and adverse events are 
uncommon. Local reactions include 
pain, erythema, swelling or itching 
at the injection site. Systemic reac-
tions include fever, arthralgia, arthri-
tis, angioedema, nausea, vomiting 
and malaise. 
d.  Role of Rabies Immune Globulin 
(RIG) #
  Anti-rabies immunoglobulin (Rabig-
am® National Bioproducts Institute, 
Pinetown, KZN) is prepared by frac-
tionation of pooled serum from im-
munized human donors. RIG is indi-
cated for all category 3 exposures. 
The method of administration is to 
infiltrate as much as possible of the 
Table I: Categories of animal exposure
Risk Category Type of exposure Action
1 Touching or feeding animal.Licking intact skin. Nil if reliable history
2
Nibbling uncovered skin.
Superficial scratch without 
bleeding.
• Wound treatment*
• Give rabies vaccine φ
• Do not give anti-rabies 
   immunoglobulin
• Stop vaccination if animal   
   negative for rabies (labora
   tory tests) or remains well 
   after 10 days observation     
   (dog or cat)
  3
Bites or scratches penetrating 
skin & drawing blood.
Licking of mucous membranes 
or broken skin.
• Wound treatment*
• Give rabies vaccine φ
• Give anti-rabies immuno
   globulin #
• Give anti-tetanus vaccine   
   and antibiotic
• Stop vaccination if animal  
   negative for rabies (labora 
   tory tests) or remains well 
   after 10 days observation 
   (dog or cat)
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RIG into the wound at a dosage of 20 
IU/kg (Rabigam - each 2 ml ampoule 
contains 300 IU). Local aneasthetic 
should not be used as it may inter-
fere with the local action of the RIG. 
The remaining RIG is given in the op-
posite deltoid to that used for the vac-
cine. If there are multiple wounds, the 
RIG can be diluted with saline by 2 or 
3 times so that all wounds are ade-
quately infiltrated. 
 RIG should be given as soon as pos-
sible after exposure, but may be ad-
ministered up to 7 days after the first 
vaccine is given. It is important not to 
exceed the maximum dose as anti-
body response to the vaccine is in-
hibited. If RIG is unavailable, active 
immunization with vaccine should not 
be delayed.  In addition, RIG should 
not be given to the patient if there is a 
history of pre- or post-exposure pro-
phylaxis. Adverse events are gener-
ally uncommon and are the same as 
for the vaccine. 
e. Special circumstances
 •  Bat exposures: PET provides 
variable protection against rabies-
related viruses.  The categories of 
exposure (Table I) do not apply 
to bats, as transmission can oc-
cur with very minor or even inap-
parent contact. Any close contact 
with bats is an indication for PET 
and should be managed as a cat-
egory 3 exposure. 
 •  Immunocompromised persons: 
RIG plus vaccine should be used 
for category 2 as well as catego-
ry 3 exposures because of de-
creased efficacy of vaccine. 
 •  Pregnant women; Pregnancy is 
not a contra-indication for the vac-
cine or RIG, if there has been a 
significant rabies exposure.    
CASE 2  
Rabies should be suspected in all se-
vere, acute neurological disease of sus-
pected viral origin especially if the dis-
ease progresses to coma and death.6 
The typical clinical presentation of ra-
bies is summarised as follows:
•  Incubation period 2-8 weeks (range: 
5 days to 1 year).
•  Onset may begin with fever, head-
ache, nausea, diarrhoea, irritability.
•  One third may report paraesthesia or 
itching at site of bite.
•  Acute neurologic phase – agitation, 
mania, hyperactivity, and hallucina-
tions interspersed with lucid periods.
Etiology Diagnosis Clinical presentation Considerations
Non-infectious Delirium tremens Confusion, agitation, 
hallucinations, uncon-
trollable tremors of the 
extremities
Only in patients with 
history of excessive al-
cohol abuse, followed 
by abstinence
Drug reaction Tremors, restless-





Strychnine poisoning Convulsions, agitation, 
restlessness, spasms
Sudden onset (within 
60 minutes of ingest-
ing the poison)
Snake bite poisoning 
(from elapid snakes)
Uncontrolled salivation 
(dribbling from mouth, 
due to throat paralysis)
A swollen bite wound 
should be present on 
the body; ptosis often 
present
Infectious Tetanus Convulsions on sud-
den stimuli, trismus, 
difficulty swallowing
Vaccination history of 
the patient must be 
considered; Patient 
will present with clear 
consciousness and no 
signs of encephalitis; 
Rabies patients usually 
don’t have sustained 
rigidity of the axial 
muscles (i.e. jaw) as 
with tetanus 





Viral encephalitis General encephalitic 
picture
No clear behavioral 
changes, no lucid pe-







clude herpes simplex 
virus and different 
arboviruses;
Travel history is an im-
portant consideration 















Patients have clear 
consciousness
Table II: Differential diagnosis for patients presenting with ’rabies-like’ illness.  
•  Rabies may present as a predomi-
nantly paralytic disease (Table II).
•  Seizures may be precipitated by au-
ditory or tactile stimuli.
•  Hydrophobia or aerophobia may oc-
cur; hypersalivation is common.
•  Death is usually due to cardio-respi-
ratory failure. 
Reliable case histories provide valu-
able information that may guide the 
medical health professional to include 
or exclude rabies as a likely cause of 
illness. Important points to address with 
suspected rabies cases will include the 
geographical locality of the possible 
exposure event, where cases from en-
demic areas should be considered of 
higher risk. Details, including ownership, 
vaccination status and behavioral char-
acteristics of the dog (or other animal) 
involved in the possible exposure are 
particularly useful. In all patients with a 
history of dog bite and where the dog 
cannot be accounted for (i.e. a stray ani-
mal or no vaccine certificate available), 
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rabies must be considered a probable 
diagnosis. A number of diagnoses may 
be considered when the case history 
indicates that rabies is not likely (Table 
II).
Clinical signs may be obscure and 
laboratory testing is important to confirm 
a suspected diagnosis, since every 
rabies-associated death should be re-
garded as a health system failure. It is 
critical that human cases of rabies are 
confirmed and notified so that the prob-
lem of rabies is recognized in the area 
and public health programmes strength-
ened. Laboratory confirmation of rabies 
in humans is however hampered by the 
limited availability of laboratory tests, 
delays in diagnosis and the requirement 
for invasive diagnostic procedures post- 
mortem. Although ante-mortem testing 
is not considered the ‘gold standard’ 
and is not 100% sensitive, it should be 
definitely attempted.  
The rapid and accurate diagnosis of 
rabies intravitam is essential to ensure 
appropriate medical management of the 
patient, which is particularly important 
when the disease is caused by a treat-
able agent and not rabies virus.   
Early indication of a case may also 
aid in timely public health intervention 
for other possible contacts and guide 
management of medical staff and the 
patient’s relatives. Routine examination 
of the CSF is generally not helpful, and 
is typically normal.  Pleocytosis may be 
found after 7 days of illness.7 Magnetic 
resonance imaging (MRI) may provide 
some insights, but computed tomogra-
phy (CT) is normal and electroencepha-
lography (EEG) usually shows diffuse 
slow wave activity.8 Several specialized 
laboratory tests are available for confir-
mation of rabies, ante- and postmortem 
(Table III). The most useful antemortem 
test is the reverse transcription poly-
merase chain reaction (RT-PCR), which 
detects the viral genome and can be 
applied to saliva, cerebrospinal fluid or 
nuchal biopsy specimens. 
Saliva is however the preferred speci-
men for testing in most laboratories. 
Fluorescent antibody test (FAT) on 
nuchal biopsies is useful but requires 
specialized equipment and may not be 
available in all testing laboratories. FAT 
on corneal impressions is also not pre-
ferred. The benchmark for postmortem 
rabies diagnosis, the fluorescent anti-
body test (FAT) detects viral antigen in 
brain smears.9 The test is 100% sensitive 














be submitted for 
testing
Saliva, not sputum 
should be used
Virus isolation
Cell culture or 
laboratory animal 
isolation of virus
Delay in results 
and not all strains 





does not exclude 
rabies virus infec-
tion
Saliva usually more 
sensitive specimen
Delay in results 
and not all strains 
may be adaptable 
to cell culture 
Antibodies in the 
CSF are regarded 
as an indication 
of infection (and 
not vaccination). 
May be present in 
cases who have 
received  rabies 
vaccine 
Virus Isolation Cell culture or laboratory animal 
isolation of virus
FAT
A negative result 
does not exclude 
rabies virus infec-
tion, and antibod-
ies may only be 
detected late 
during disease 
(typically after 5 
days of infection)  
Serum FAT As for CSF
Detect antibody 
after vaccination 






proaches 100 % 
in experienced 
laboratories




Sensitive, and may 
be especially use-
ful for specimens 
fixed in formalin
Virus isolation
Cell culture or 
laboratory animal 
isolation of virus
Tests not routinely available in testing laboratories are not included. 
when performed in experienced labora-
tories. When an autopsy is not agreed to 
by the patient’s relatives, the collection 
of a brain biopsy through the superior 
orbital fissure is suggested.10  Postmor-
tem diagnosis through histology may 
also be useful but is less sensitive than 
the aforementioned tests.11 Microscopic 
investigation of stained sections of hip-
pocampus, brain stem and cerebellum 
revealing oval-shaped inclusion bodies 
known as Negri bodies are considered 
a positive indication of rabies virus 
infection. Important points regarding 
the laboratory diagnosis of rabies virus 
infection which are often a source of 
uncertainty are as follows:
•  There is no blood test to confirm 
 rabies virus infection (or exposure). 
  Rabies virus is not viraemic and can-
not be detected in blood specimens. 
Serum antibodies as a response 
to infection are produced late dur-
ing disease, and are not  reliable 
for diagnosis. Detection of serum 
antibodies in unvaccinated patients 
may however be diagnostic, but 
usually only appears late during the 
disease.
•  Sequential saliva specimens should 
be submitted for laboratory testing 
in clinically suspected cases (intra 
vitam). Saliva specimens are the 
preferred specimens for laboratory 
Review
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diagnosis in most laboratories, but 
importantly, a negative result does 
not exclude rabies virus infection (es-
pecially in early disease) and testing 
sequential specimens is important.
•  Postmortem diagnosis of suspected 
rabies cases does not only provide 
closure for the patient’s relatives but 
also provides important information to 
authorities to motivate better control 
strategies in animals or distribution 
of prophylaxis. Brain (complete 
in two halves, or pieces or trucut 
needle biopsies of preferably the 
cerebellum and brainstem,  in 50% 
glycerol buffered saline (in screw 
cap containers) should be sent to 
reach the testing laboratory as soon 
as possible after collection.
Rabies has 100% mortality and there 
is no specific management for pa-
tients. Sedation of the patient12, sup-
portive care should be considered, 
and although there has never been a 
person-to-person transmission other 
than through rare transplantation cases, 
infection control procedures for heath 
care workers should be instituted by the 
use of personal protective equipment. 
Rabies immunoglobulin and vaccine 
play no role once clinical disease is ap-
parent. To date there has been only one 
human rabies disease survivor without 
any PET, a young girl who developed 
rabies following on a bat exposure, 
and who survived following on induced 
coma, critical care support and the use 
of antiviral agents.12  
CASE 3 
People with increased occupational risk 
of exposure to infection, such as vet-
erinary staff, wildlife handlers, laboratory 
personnel working with rabies virus or 
animal welfare staff, should receive pre-
exposure prophylaxis by administration 
of three doses of vaccine into the deltoid 
muscle on days 0, 7 and 28.
Persons who have received pre-ex-
posure vaccination must be given two 
booster doses of vaccine if there is ex-
posure to a suspected rabid animal. 
These are given on days 0 and 3. Ra-
bies immune globulin should be omit-
ted post exposure since it may depress 
the rapid boosting of antibodies. It is not 
clear how often boosters should be giv-
en in this group of people with ongo-
ing potential exposure; some authorities 
recommend boosters every 3-5 years. 
Measurement of serum antibody levels 
by neutralization testing may guide the 
process. A recent study demonstrated 
that even after 18 years, a single vac-
cine booster will result in a rapid and 
significant increase in antibody titers.  
Rabies and the traveler: Rabies is an 
important disease for the traveling com-
munity.  Canine and feline rabies are en-
demic in the developing countries of 
Asia, Africa and South America.  This 
poses a particular threat in the back-
packing or adventure category.  Pre-
exposure rabies vaccination, as above, 
should be considered. Pre-exposure im-
munization obviates the need for post-
exposure rabies immunoglobulin, a 
commodity which is often unavailable in 
many countries.
Conclusions: 
Human rabies in South Africa is largely 
due to infection with the classical rabies 
virus (genotype 1), with the yellow mon-
goose the commonest vector except in 
KwaZulu-Natal, Eastern Cape, Mpuma-
langa and now Limpopo provinces where 
the dog is predominantly responsible for 
most bites. Rabies is always fatal in 
humans and post-exposure prophylaxis 
(PEP) or post-exposure treatment (PET) 
is appropriate immediately after a bite. 
PEP follows a schedule of 3 doses of 
vaccine in the deltoid muscle on days 
0, 7 and 28, and patients who had pre-
exposure vaccination receive only two 
vaccine booster doses on days 0 and 
3, with new exposure to a suspected 
rabid animal. Finally, there is no blood 
test to confirm rabies virus infection (or 
exposure), hence it is unnecessary to 
request such test when confronted with 
a patient possibly exposed to rabies. 
Table IV lists important health promotion 
messages for the community.
Acknowledgement: 
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Table IV: Important health promotion messages for the community
1. Rabies kills; Have your dog or cat vaccinated against 
rabies every year 
2.  Do not touch wild or stray  animals 
3.  It is critical to educate children to report any animal bite or 
scratch even, 
  even if from their own or neighbour’s pet (90% of  rabies 
cases are in children)  
4.  All animal  bites and scratches must be washed thoroughly 
with water for at least 5 minutes before going to the clinic/
hospital
5.  All people bitten by animal must go to the clinic/hospital for 
preventative treatment
for the permission to reprint the major 
vectors of the disease involved as indi-
cated on the diagram (Figure 1).
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